Sanofi SA (SNY)
52.94
-0.33
(-0.62%)
USD |
NASDAQ |
Nov 04, 16:00
52.93
-0.01
(-0.02%)
After-Hours: 20:00
Sanofi Market Cap: 132.70B for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 133.56B |
| October 31, 2024 | 132.58B |
| October 30, 2024 | 134.01B |
| October 29, 2024 | 134.96B |
| October 28, 2024 | 136.29B |
| October 25, 2024 | 136.24B |
| October 24, 2024 | 130.50B |
| October 23, 2024 | 132.60B |
| October 22, 2024 | 133.53B |
| October 21, 2024 | 134.53B |
| October 18, 2024 | 137.72B |
| October 17, 2024 | 137.54B |
| October 16, 2024 | 136.49B |
| October 15, 2024 | 136.82B |
| October 14, 2024 | 137.69B |
| October 11, 2024 | 137.79B |
| October 10, 2024 | 137.32B |
| October 09, 2024 | 138.27B |
| October 08, 2024 | 137.52B |
| October 07, 2024 | 137.29B |
| October 04, 2024 | 139.07B |
| October 03, 2024 | 139.25B |
| October 02, 2024 | 141.03B |
| October 01, 2024 | 143.69B |
| September 30, 2024 | 144.49B |
| Date | Value |
|---|---|
| September 27, 2024 | 144.52B |
| September 26, 2024 | 142.89B |
| September 25, 2024 | 142.01B |
| September 24, 2024 | 144.45B |
| September 23, 2024 | 143.97B |
| September 20, 2024 | 144.47B |
| September 19, 2024 | 146.05B |
| September 18, 2024 | 144.07B |
| September 17, 2024 | 142.67B |
| September 16, 2024 | 143.72B |
| September 13, 2024 | 143.22B |
| September 12, 2024 | 142.26B |
| September 11, 2024 | 144.04B |
| September 10, 2024 | 145.72B |
| September 09, 2024 | 146.68B |
| September 06, 2024 | 144.72B |
| September 05, 2024 | 146.00B |
| September 04, 2024 | 146.73B |
| September 03, 2024 | 144.22B |
| August 30, 2024 | 141.02B |
| August 29, 2024 | 141.19B |
| August 28, 2024 | 140.64B |
| August 27, 2024 | 141.17B |
| August 26, 2024 | 141.04B |
| August 23, 2024 | 140.89B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
93.35B
Minimum
Sep 27 2022
146.73B
Maximum
Sep 04 2024
124.85B
Average
125.64B
Median
Market Cap Benchmarks
| AstraZeneca PLC | 221.44B |
| Eli Lilly and Co | 765.28B |
| Pfizer Inc | 157.31B |
| Regeneron Pharmaceuticals Inc | 91.08B |
| Novavax Inc | 1.460B |
Market Cap Related Metrics
| PE Ratio | 26.82 |
| PS Ratio | 2.498 |
| Price to Book Value | 1.703 |
| Price | 52.94 |
| Earnings Yield | 3.73% |
| Operating PE Ratio | 11.54 |
| Normalized PE Ratio | 16.52 |